Which funds bought or sold CME in Q3 2026?
Cme Group Inc. 7 funds bought, 11 sold, out of 109 tracked funds that have filed for Q3 2026. Among active managers, the estimated net flow was +$902M. See also what famous investors say about CME.
Holdings as of Sep 30, 2026 (Q3 2026)13F deadline Nov 16, 2026 (45 days after quarter end)
- JPMorgan+$892M
- Wellington+$587M
- Schwab+$195M
- Capital Research+$191M
- Capital World+$189M
- CalPERS+$39M
- Baupost+$17M
- QRT−$416M
- Marshall Wace−$318M
- Jane Street−$308M
- Goldman Sachs−$260M
- Millennium−$184M
- Arrowstreet−$170M
- Renaissance−$54M
- Legal & General−$49M
- Tudor−$39M
- VikingOUT−$34M
Top 10 each side. NEW = opened a position, OUT = sold the whole position.
Bought (7)
| Fund | Change | Est. $ | Now |
|---|---|---|---|
| JPMorgan Bank & broker | Added+58.8% | +$892M | $2.4B |
| Wellington Asset manager | Added+123.4% | +$587M | $1.1B |
| Schwab Index giant | Added+34.1% | +$195M | $767M |
| Capital Research Asset manager | Added+61.1% | +$191M | $504M |
| Capital World Asset manager | Added+10.6% | +$189M | $2.0B |
| CalPERS Sovereign & pension | Added+23.4% | +$39M | $208M |
| Baupost Value investor | Added+10.7% | +$17M | $180M |
Sold (11)
| Fund | Change | Est. $ | Now |
|---|---|---|---|
| QRT Quant & multi-strategy | Trimmed-98.5% | −$416M | $6M |
| Marshall Wace Quant & multi-strategy | Trimmed-54.1% | −$318M | $269M |
| Jane Street Quant & multi-strategy | Trimmed-64.9% | −$308M | $167M |
| Goldman Sachs Bank & broker | Trimmed-27.4% | −$260M | $689M |
| Millennium Quant & multi-strategy | Trimmed-58.7% | −$184M | $129M |
| Arrowstreet Quant & multi-strategy | Trimmed-20% | −$170M | $683M |
| Renaissance Quant & multi-strategy | Trimmed-30.2% | −$54M | $124M |
| Legal & General Asset manager | Trimmed-8.3% | −$49M | $548M |
| Tudor Hedge fund | Trimmed-58.6% | −$39M | $28M |
| Viking Hedge fund | Sold out | −$34M | — |
| Hudson Bay Quant & multi-strategy | Trimmed-97.9% | −$17M | $356K |
Source: SEC EDGAR Form 13F-HR for each fund, holdings as of Sep 30, 2026. Shares only (options excluded). Estimated $ = change in shares × quarter-end price. Funds may have traded since. Methodology. Not investment advice.